Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons
Authors:
- 1 January 1991
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 6 (1) , 35-40
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related DideoxynucleosidesNew England Journal of Medicine, 1989
- Progression to AIDS in patients with lymphadenopathy or AIDS-related complex: reappraisal of risk and predictive factorsThe American Journal of Medicine, 1989
- Survival with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Effects of patients' socioeconomic status and physicians' training and practice on patient-doctor communicationThe American Journal of Medicine, 1985
- The national profile of access to medical care: where do we stand?American Journal of Public Health, 1984
- Taking Care of the Hateful PatientNew England Journal of Medicine, 1978
- Hidden Values and Health CareMedical Care, 1974